These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2861293)

  • 1. Effect of prednisolone on the toxicity of Bordetella pertussis for mice.
    Parton R
    J Med Microbiol; 1985 Jun; 19(3):391-400. PubMed ID: 2861293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-inflammatory agents on the haemorrhagic response of mouse skin to Bordetella pertussis heat-labile toxin.
    Parton R
    J Med Microbiol; 1986 May; 21(3):265-70. PubMed ID: 3701831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of Bordetella pertussis heat-labile toxin with human embryonic lung cells.
    Frampton HK; Freer JH; Birkbeck TH; Wardlaw AC
    J Med Microbiol; 1991 Jan; 34(1):45-50. PubMed ID: 1990137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and properties of Bordetella pertussis heat-labile toxin.
    Livey I; Wardlaw AC
    J Med Microbiol; 1984 Feb; 17(1):91-103. PubMed ID: 6319705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic studies of the molecular basis of whooping cough.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    Dev Biol Stand; 1985; 61():11-9. PubMed ID: 2872097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics of Bordetella pertussis toxins.
    Antoine R; Raze D; Locht C
    Int J Med Microbiol; 2000 Oct; 290(4-5):301-5. PubMed ID: 11111902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of the heat-labile toxin of Bordetella pertussis.
    Zhang YL; Sekura RD
    Infect Immun; 1991 Oct; 59(10):3754-9. PubMed ID: 1894374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
    Siniashina LN; Siniashina LS; Semin EG; Amelina IP; Karataev GI
    Mol Gen Mikrobiol Virusol; 2010; (3):31-6. PubMed ID: 20886687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions in the foot pads of mice induced by pertussigen and endotoxin from Bordetella pertussis.
    Munoz JJ; Robbins KE; Cole RL
    J Reticuloendothel Soc; 1980 Mar; 27(3):259-68. PubMed ID: 6245208
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
    Hormozi K; Parton R; Coote J
    Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and purification of Bordetella pertussis toxin.
    Ju CL; Sheu GC; Cheng Y; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):72-83. PubMed ID: 10592813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis.
    Ben-Nun A; Yossefi S; Lehmann D
    Eur J Immunol; 1993 Mar; 23(3):689-96. PubMed ID: 8095458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turkey coryza: selected tests for detection and neutralization of Bordetella avium heat-labile toxin.
    Rimler RB; Rhoades KR
    Avian Dis; 1986; 30(4):808-12. PubMed ID: 3814017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heptakis (2,6-0-dimethyl)beta-cyclodextrin on cell growth and the production of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis.
    Suzuki Y; Imaizumi A; Ginnaga A; Sato H; Sato Y
    Dev Biol Stand; 1985; 61():89-92. PubMed ID: 2872134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.